Position in LLY
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$4,909,430,574
-$930,995,806 QoQ
Shares Held
5,337,672
-1.8% QoQ
Ownership
0.567%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Nuveen, LLC holds $15,758,594,016 across 13 Drug Manufacturers - General names. LLY ranks #1 (31.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,337,672 | $4,909,430,574 | |
| 2 | JNJ |
Johnson & Johnson
|
12,490,455 | $3,053,166,819 | |
| 3 | ABBV |
AbbVie Inc.
|
11,115,159 | $2,417,435,929 | |
| 4 | AZN |
Astrazeneca PLC
|
6,779,534 | $1,337,059,694 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,099,764 | $1,214,900,610 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,833,564 | $1,091,763,813 | |
| 7 | AMGN |
Amgen Inc
|
2,416,399 | $850,209,986 | |
| 8 | PFE |
Pfizer Inc
|
13,178,661 | $370,056,799 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,909,430,574 | 5,337,672 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $5,840,426,380 | 5,434,572 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $4,133,000,088 | 5,416,776 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,435,317,564 | 5,689,733 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,613,912,351 | 5,586,459 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||